Dr. Lidija Marusic, senior advisor of business ventures with Innovacorp, has been appointed to the Canadian Institutes of Health Research (CIHR) Proof of Principle (POP) program peer review committee.

Lidija has 15 years of experience in commercialization, venture capital and academic research. She holds a Doctor of Medicine degree from the University of Zagreb in Croatia, a PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy, and an MBA from McMaster University in Hamilton, Ontario.

CIHR is the major federal agency responsible for funding health research in Canada. It aims to excel in the creation of new health knowledge, and to translate that knowledge from the research setting into real world applications. The results are improved health for Canadians, more effective health services and products, and a strengthened Canadian health care system.

The POP program supports proof of principle research projects of up to 12 months duration designed to advance discoveries and inventions towards commercializable technologies, with a view to attract new investment and create new science-based businesses.

The POP peer review committee is comprised of experts in health research, intellectual property management, technology transfer, commercialization, institute-industry relationships, entrepreneurship, and venture capital investment. Applications are assessed on both research excellence and commercial potential.

As a member of the committee, Lidija will participate in peer review meetings in Ottawa.

For more information, please contact:
Jennifer Batten
Marketing and Communications
Innovacorp
902.424.8670 x 1197
JBATTEN@INNOVACORP.CA

Halifax, Nova Scotia, July 31, 2007